Yuka Yamagishi Selected Research

garenoxacin

11/2019	Comparison of the in Vivo Activities of Garenoxacin and Levofloxacin in a Murine Model of Pneumonia by Mixed-Infection with Streptococcus pneumoniae and Parvimonas micra.
6/2015	Pharmacokinetic study of garenoxacin in severe renal failure patients.
4/2010	[Antimicrobial activity of oral quinolones against clinical isolates of Bifidobacterium group and Clostridium difficile].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuka Yamagishi Research Topics

Disease

41	Infections 05/2022 - 10/2009
15	Pneumonia (Pneumonitis) 05/2022 - 06/2011
10	Bacteremia 12/2021 - 02/2012
8	Sepsis (Septicemia) 12/2021 - 10/2010
7	Communicable Diseases (Infectious Diseases) 01/2021 - 10/2010
6	Wilms Tumor (Wilm's Tumor) 06/2022 - 06/2019
5	Inflammation (Inflammations) 08/2021 - 10/2012
4	Aspiration Pneumonia 10/2021 - 03/2016
4	Fever (Fevers) 08/2021 - 04/2017
4	Coinfection 06/2021 - 06/2017
4	Peritonitis 01/2016 - 10/2009
3	Leukemia 06/2022 - 04/2016
3	Healthcare-Associated Pneumonia 01/2022 - 12/2011
3	Thrombocytopenia (Thrombopenia) 08/2021 - 10/2015
3	Necrotizing Fasciitis 06/2021 - 11/2020
3	Diarrhea 01/2020 - 04/2010
3	Neoplasms (Cancer) 04/2019 - 07/2007
3	Body Weight (Weight, Body) 09/2018 - 07/2016
3	Mycoses (Diseases, Fungus) 09/2018 - 06/2013
2	Empyema 05/2022 - 10/2017
2	Vulvovaginal Candidiasis 01/2022 - 02/2016
2	Adenocarcinoma 12/2021 - 08/2021
2	Dysbiosis 08/2021 - 01/2020
2	Gram-Positive Bacterial Infections 08/2021 - 09/2018
2	COVID-19 07/2021 - 01/2021
2	Staphylococcal Infections 05/2020 - 01/2019
2	Renal Insufficiency (Renal Failure) 03/2020 - 06/2015
2	Cryptococcosis 05/2019 - 06/2013
2	Human Influenza (Influenza) 01/2019 - 10/2017
2	Endophthalmitis (Ophthalmia) 01/2019 - 10/2012
2	Invasive Fungal Infections 09/2018 - 09/2015
2	Cross Infection (Nosocomial Infection) 01/2018 - 04/2014
2	Respiratory Tract Infections (Respiratory Tract Infection) 11/2017 - 06/2015
2	Sinusitis 10/2017 - 11/2016
2	Pneumococcal Infections 06/2017 - 07/2014
2	Hypersensitivity (Allergy) 04/2017 - 09/2015
2	Meningitis 11/2016 - 08/2011
2	Intraabdominal Infections 10/2016 - 10/2013
2	Uterine Cervicitis (Cervicitis) 06/2012 - 08/2011

Drug/Important Bio-Agent (IBA)

16	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 04/2010
11	Pharmaceutical PreparationsIBA 04/2022 - 05/2009
6	Peptides (Polypeptides)IBA 06/2022 - 06/2019
6	Vancomycin FDA LinkGeneric 05/2022 - 04/2014
6	Carbapenems (Carbapenem Antibiotics)IBA 10/2021 - 10/2013
6	Linezolid (Zyvox)FDA Link 08/2021 - 10/2015
6	MacrolidesIBA 03/2021 - 10/2009
5	Daptomycin FDA Link 05/2022 - 04/2017
5	Levofloxacin (Levaquin)FDA Link 06/2021 - 08/2011
4	EchinocandinsIBA 05/2022 - 10/2012
4	Azithromycin (Zithromax)FDA LinkGeneric 03/2022 - 04/2010
4	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 10/2021 - 02/2012
4	Meropenem (Merrem)FDA LinkGeneric 09/2021 - 08/2011
4	QuinolonesIBA 06/2021 - 10/2009
4	Itraconazole (Sporanox)FDA LinkGeneric 02/2016 - 10/2009
3	Moxifloxacin (Avelox)FDA Link 03/2022 - 04/2010
3	Immune Checkpoint InhibitorsIBA 12/2021 - 06/2019
3	ProcalcitoninIBA 12/2021 - 06/2021
3	protectin D1IBA 08/2021 - 01/2020
3	16S Ribosomal RNAIBA 05/2021 - 11/2016
3	FluoroquinolonesIBA 03/2021 - 01/2014
3	garenoxacinIBA 11/2019 - 04/2010
3	liposomal amphotericin B FDA Link 09/2018 - 10/2010
3	Micafungin (FK463)FDA Link 01/2018 - 10/2012
3	Colistin (Coly-Mycin)FDA Link 03/2017 - 10/2016
3	arbekacinIBA 07/2016 - 08/2012
2	Messenger RNA (mRNA)IBA 06/2022 - 01/2018
2	Oxygen (Dioxygen)IBA 05/2022 - 06/2016
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 05/2022 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2011
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 10/2021 - 06/2019
2	carbapenemaseIBA 09/2021 - 05/2021
2	nacubactamIBA 09/2021 - 05/2021
2	Aztreonam FDA LinkGeneric 09/2021 - 05/2021
2	Cefepime (Maxipime)FDA LinkGeneric 09/2021 - 05/2021
2	LactamsIBA 09/2021 - 05/2021
2	C-Reactive ProteinIBA 08/2021 - 01/2016
2	AntigensIBA 07/2021 - 07/2007
2	Amphotericin B (Amphotericin)FDA LinkGeneric 05/2021 - 09/2018
2	Ciprofloxacin (Cipro)FDA LinkGeneric 02/2021 - 10/2013
2	PicibanilIBA 10/2020 - 06/2019
2	Metronidazole (Metric)FDA LinkGeneric 12/2019 - 11/2018
2	Oseltamivir (Tamiflu)FDA Link 01/2019 - 10/2017
2	Clindamycin (Cleocin)FDA LinkGeneric 12/2018 - 06/2016
2	Conjugate VaccinesIBA 06/2017 - 07/2014
2	CreatinineIBA 03/2017 - 07/2016
2	Voriconazole (Vfend)FDA LinkGeneric 09/2016 - 02/2014
2	Fluconazole (Zonal)FDA LinkGeneric 02/2016 - 10/2012
2	Antifungal AgentsIBA 06/2013 - 10/2012
2	Erythromycin (Erycette)FDA LinkGeneric 06/2012 - 06/2009
2	Clarithromycin (Biaxin)FDA LinkGeneric 06/2012 - 06/2012
2	Anti-Infective Agents (Microbicides)IBA 04/2010 - 04/2010

Therapy/Procedure

27	Therapeutics 05/2022 - 07/2007
12	Drug Therapy (Chemotherapy) 12/2021 - 12/2011
5	Catheters 08/2021 - 03/2016
3	Immunotherapy 06/2022 - 06/2019
3	Central Venous Catheters 11/2020 - 04/2014
3	Debridement 05/2019 - 06/2016
3	Renal Dialysis (Hemodialysis) 09/2018 - 06/2015
2	Length of Stay 03/2021 - 12/2015
2	Lasers (Laser) 02/2019 - 11/2016